At the news
? NEUTRALIMPACT 3/10 S-3 filed Apr 27, 2026 at 16:11 ET
Vor Biopharma filed an S-3 registration statement to register 5,338,078 shares of common stock for resale by TCG Crossover Funds, issued in a March 2026 private placement at $14.05/share ($75M gross). The company will not receive any proceeds. This is a routine registration rights fulfillment and does not represent new equity issuance or capital raise.
- Registers 5,338,078 shares for resale by selling stockholders (TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P.)
- Shares were issued in a private placement on March 30, 2026 at $14.05 per share, gross proceeds ~$75M to the company
- Company will not receive any proceeds from this resale offering
- Stock closed at $13.81 on April 24, 2026; market cap ~$675M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access